Mankelow, T. J., Singleton, B. K., Moura, P. L., Stevens‐Hernandez, C. J., Cogan, N. M., Gyorffy, G., Kupzig, S., Nichols, L., Asby, C., Pooley, J., Ruffino, G., Hosseini, F., Moghaddas, F., Attwood, M., Noel, A., Cooper, A., Arnold, D. T., Hamilton, F., Hyams, C., Finn, A., Toye, A. M., & Anstee, D. J. (2021). blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications. EJHaem, 2(2), 175–187. http://access.bl.uk/ark:/81055/vdc_100130250307.0x000003